Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease

Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease

Vo Van Giau,1,* Hyon Lee,2,* Kyu Hwan Shim,1 Eva Bagyinszky,1 Seong Soo A An1 1Department of Bionano Technology, Gachon University, Seongnam, South Korea; 2Department of Neurology, Gachon University Gil Medical Center, Incheon, South Korea *These authors contributed equally to this work Abstract:...

Full description

Bibliographic Details
Main Authors: Giau VV, Lee H, Shim KH, Bagyinszky E, An SSA
Format: Article
Language:English
Published: Dove Medical Press 2018-02-01
Series:Clinical Interventions in Aging
Subjects:
Alzheimer's disease
CRISPR-Cas9
mutation
Aβ42/40 ratio
Online Access:https://www.dovepress.com/genome-editing-applications-of-crispr-cas9-to-promote-in-vitro-studies-peer-reviewed-article-CIA

Internet

https://www.dovepress.com/genome-editing-applications-of-crispr-cas9-to-promote-in-vitro-studies-peer-reviewed-article-CIA

Similar Items